Zobrazeno 1 - 4
of 4
pro vyhledávání: '"W J F M, van der Velden"'
Autor:
H. R. Wardill, C. E. M. de Mooij, A. R. Da Silva Ferreira, H. Havinga, H. J. M. Harmsen, W. J. F. M. van der Velden, L. F. J. van Groningen, W. J. E. Tissing, N. M. A. Blijlevens
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract High-dose chemotherapy causes intestinal inflammation and subsequent breakdown of the mucosal barrier, permitting translocation of enteric pathogens, clinically manifesting as fever. Antibiotics are mainstay for controlling these complicatio
Externí odkaz:
https://doaj.org/article/5ddb7407c921495ab646fed28b4b3926
Autor:
C. E. M. de Mooij, W. J. F. M. van der Velden, A. F. J. de Haan, S. Fazel, L. F. J. van Groningen, N. M. A. Blijlevens
Publikováno v:
Bone Marrow Transplantation, 57, 9, pp. 1373-1381
Bone Marrow Transplantation, 57, 1373-1381
Bone Marrow Transplantation, 57, 1373-1381
Item does not contain fulltext Earlier studies have suggested that severe intestinal mucositis (IM; citrulline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d102ca1ee9995f02833ee06d17d05ec
https://repository.ubn.ru.nl/handle/2066/282628
https://repository.ubn.ru.nl/handle/2066/282628
Autor:
C E M, de Mooij, W J F M, van der Velden, A F J, de Haan, S, Fazel, L F J, van Groningen, N M A, Blijlevens
Publikováno v:
Bone marrow transplantation. 57(9)
Earlier studies have suggested that severe intestinal mucositis (IM; citrulline 10 µmol/L) is an independent risk factor for bloodstream infections (BSI) after cytotoxic therapy. Our aim was to grade IM in patients receiving commonly used chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a36707aeed3730cbfecf0ac021b3e641
https://pubmed.ncbi.nlm.nih.gov/35661156
https://pubmed.ncbi.nlm.nih.gov/35661156
Autor:
G J, Ossenkoppele, D A, Breems, G, Stuessi, Y, van Norden, M, Bargetzi, B J, Biemond, P, A von dem Borne, Y, Chalandon, J, Cloos, D, Deeren, M, Fehr, B, Gjertsen, C, Graux, G, Huls, J J J W, Janssen, A, Jaspers, M, Jongen-Lavrencic, E, de Jongh, S K, Klein, M, van der Klift, M, van Marwijk Kooy, J, Maertens, L, Michaux, M W M, van der Poel, A, van Rhenen, L, Tick, P, Valk, M C, Vekemans, W J F M, van der Velden, O, de Weerdt, T, Pabst, M, Manz, B, Löwenberg, M, Van Marwijk Kooy
Publikováno v:
Leukemia. 34(7)
More effective treatment modalities are urgently needed in patients with acute myeloid leukemia (AML) of older age. We hypothesized that adding lenalidomide to intensive standard chemotherapy might improve their outcome. After establishing a safe len
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da184de984c87878475706a1b6cbe670
https://pubmed.ncbi.nlm.nih.gov/32733013
https://pubmed.ncbi.nlm.nih.gov/32733013